Studies on O-specific polysaccharides of Shigella flexneri 1b(I) and its smooth mutant Z(III)  by Romanowska, E. & Lachowicz, T.M.
Volume 8, number 5 FEBS LETTERS June 1970 
STUDIES ON O-SPECIFIC POLYSACCHARIDES OF SHIGELLA FLEXNERI  1 b(I) 
AND ITS SMOOTH MUTANT Z(II I) 
E.ROMANOWSKA and T.M.LACHOWlCZ 
Institute of Immunology and Experimental Therapy, Wrodaw, Poland 
Received 27 April 1970 
1. Introduction 
The O-antigen, a constitutive part of the cell walls 
of Gram-negative bacteria is a complex composed of 
O-specific polysaccharide and lipid. It has been shown 
(for review see [la]) that the polysaccharide moiety 
of lipopolysaccharides consists of an inner core region 
(core polysaccharide) to which outer serologicaUy 
specific polysaccharide chains (O-specific side chains) 
are attached. 
Shigella flexneri O-antigens have been studied 
extensively by Simmons et al. [1-3].  These investi- 
gations elucidated the chemical composition of lipo- 
polysaccharides of serotypes la, 2a, 3a, 4a, 5a, 6, 
variants X and Y, and the structure of the core poly- 
saccharide characteristic for Shigella flexneri. They 
also yielded information on the structure of O-specific 
side chains of the serotypes mentioned above. 
According to these results, Shigella flexneri produces 
a cell wall lipopolysaccharide in which the core poly- 
saccharide portion of the polymer has the following 
structure: 
H. ep 
ct-GlcNAc- 1 ~4-Gal- 1~3-Glc .. . . .  Oep 
Hep 
o~-Glc a-Glc 
The O-specific portion of the polymer from Shigella 
flexneri s composed of a number of repeating units 
which form a primary unbranched chain of N-acetyl- 
gl'acosamine and rhamnose (molar proportion 1:2), 
substituted with secondary side chains of a-glucose. 
ct-Glucosyl residues play an immunodominant role 
in antigenic factors I, II, IV, V and 7, 8. For the 
specificity of type antigen III, the important residue 
is O-acetyl-~-glucose. 
It was observed that Shigella flexneri strains of 
serotype lb (I, 3, 4, 6) split off the smooth mutant Z 
in which antigen type I is substituted for antigen type 
III, while group antigens 3, 4, 6 remain unaltered [4]. 
The mutant Z (III, 3, 4, 6) can be easily selected 
using one of the Shigellaflexneri phages (F2) [5] or 
by serial passages of the original strain through white 
mice [6]. A similar alteration in antigen type of sero- 
type 1 b was also found in lac ÷ recombinants obtained 
in crosses with Escherichia coli Hfr strains [7]. 
The present study was undertaken to explain the 
biochemical sense of the mutation described above. 
The chemical composition of the carbohydrate 
moiety of lipopolysaccharides of train 1 b(I) and its 
mutant Z(III) were defined. The lipopolysaccharides 
of R(rough)-forms of these two strains were also 
studied in this respect. 
2. Materials and methods 
Shigellaflexneri strain 6713 of serotype lb(I) 
(stock collection of our Institute) and its mutant Z(III) 
were used in the experiments. The growth of the 
bacteria in liquid medium and the phenol-water xtrac- 
tion of the dry bacterial mass [8] were performed as 
already described [9]. The purification of lipopoly- 
saccharide (LPS) from phenol-water xtracts was done 
by Sepharose 2B gel filtration [10]. 
Mild acid hydrolysis of LPS with 1% CHaCOOH 
(100 °, 1.5 hr) to obtain the free polysaccharide and 
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Fig. 1. Fractionation of polysaccharide lb(I) (22 mg) on 
Sephadex G 50 (18 X SO0 mm) equilibrated with pyridine- 
CH$OOH buffer (pK 5.75, 10 ml of pyridine and 2 ml of 
acetic acid per liter); flow rate: 1.5 ml fraction per 30 min. 
Absorbance was measured at 490 nm for the phenol- 
sulphuric scid reaction (0.1 ml of fraction tested) and at 
548 nm for the thiobarbituric acid reaction (0.2 ml of frac- 
tion tested). 
the subsequent fractionation of the latter on Sephadex 
G 50 were performed as by Schmidt et al. [l I]. 
Analytical determinations and paper chromato- 
graphy of sugars were carried out as described [9, IO] 
O-Acetyl groups were assayed according to Hestrin 
[121. 
3. Results 
During gel filtration on Sephadex G 50, the poly- 
saccharide preparations obtained after CH,COOH 
degradation of LPS I b(1) and LPS Z(lII) were separ- 
ated into four fractions: P,, P2, P3 and 2-keto-3-de- 
oxyoctonic acid (KDO) (figs. 1 and 2). The analytical 
data for lyophilized P,, P, and Pg fractions are col- 
lected in table 1. For comparison, the sugar compo- 
sitions of lipopolysaccharides isolated from 1 b(I) 
strain, mutant Z(M) and their R-forms are also shown 
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Fig. 2. Fractionation of polysaccharide Z(IlI) (19 mg) on 
Sephadex G SO. For details we. the legend to fig. 1. 
there. As may be seen, LPS lb(I) and LPS Z(III) had 
the same sugar components: rhamnose, N-acetyl- 
glucosamine, glucose, galactose, heptose and KDO, 
with the difference that LPS Z(III) contained less 
glucose and more rhamnose than LPS 1 b(1). Lipopoly- 
saccharides from R-forms of lb(I) strain and mutant 
Z(III) were almost free of rhamnose; their constitu- 
ent glucose, galactose and heptose were in the approx- 
imate molar ratios, 3: 1:2, in both lipopolysaccharides, 
giving evidence that they represent ShigelIaflexnet-i 
chemotype Ra of complete core structure [Z] 
Both P1 fractions indicated O-specific side chain 
character, but their compositions were different. P1 
fraction of lb(I) strain contained mainly glucose, 
Nacetylglucosamine, rhamnose and O-acetyl groups 
in the molar proportions 1.2 : 0.87 : 2.0 : 1.0, respec- 
tively. P, fraction of mutant Z(III) was almost de- 
void of glucose (the 2.5% of glucose constituted pro- 
bably the contamination derived from core poly- 
saccharide); this fraction was composed predominant- 
ly of N-acetylglucosamine, rhamnose and 0-acetyl 
groups in the molar ratios 0.83 : 2.0 : 0 : 1 .O, respec- 
tively. 
P, fractions of lb(I) strain and mutant Z(M) did 
not differ in their sugar composition. They consisted 
of N-acetylglucosamine, glucose, galactose, heptose, 
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Table 1 
Sugar composition (in percentage *) of lipopolysaccharides and their polysaccharide fractions isolated from Shigella flexneri lb(I), 
its smooth mutant Z(III) and their R-forms. 
Lipopolysaccharides Polysaccharide fractions 
Components * S-Forms R-Forms lb(I) Z(III) 
lb(I) Z(III) lb(I) Z(III) P1 P2 P3 P1 P2 P3 
Rhamnose 17.2 24.2 ~<0.7 ~1.2 32.0 30.5 3.4 58.3 31.8 3.6 
N-Acetylglucosamine 14.6 16.2 11.2 11.1 19.2 14.2 9.9 32.5 14.8 9.8 
Glucose 11.1 4.3 10.2 9.9 22.0 11.9 20.2 2.5 10.4 20.0 
O-Acetyl groups 2.6 3.2 n.d. n.d. 4.1 n.d. n.d. 7.5 4.0 n.d. 
Galactose 1.9 1.8 3.3 3.1 ~ (1.8 n.d. 6.2 ~0.8 n.d. 6.1 
Heptose 3.4 3.0 8.4 8.1 1.6 5.6 14.8 1.4 n.d. 14.2 
2-Keto-3-deoxyoctonic acid 4.2 4.0 8.0 7.7 0.3 0.7 2.8 0.4 0:9 3.1 
*'%' = 100 (wt. of free sugar/wt, of polysaccharide analysed). 
n.d. = not determined. 
and KDO in the molar proportions 1.2 : 3.0 : 0.9 : 1.8 : 
0.34, although some contamination by O-specific side 
chain component like rhamnose also occurred. Thus 
P3 fractions appeared as polysaccharides of  the chemo- 
type Ra characteristic for Shigella flexneri complete 
basal structure. 
P2 fractions were obtained in very small quantities 
(less than 25% of the yield of P1 fraction). They con- 
tained O-specific as well as core polysaccharide com- 
ponents. After rechromatography on Sephadex G 50, 
the P2 fraction eluted at the same volume and its 
composition did not alter appreciably, indicating that 
it was not a mixture o fP  1 and P3 fractions. It seems 
probable that the P2 fraction constitutes a product of 
breakage of LPS lb(I) or LPS Z(III) in the external 
(O-specific) part so that shorter O-specific side chains 
and fragments of  these chains attached to core poly- 
saccharide are formed. 
2-Keto-3-deoxyoctonic acid was identified in the 
last fraction eluted from Sephadex G 50. No other 
monosaccharides were found except a trace of rham- 
nose. 
4. Discussion 
The repeating unit of the O-specific side chain of 
Shigellaflexneri lb(I) is composed of 1 molecule of 
glucose, 1 molecule ofN-acetylglucosamine, 2 mole- 
cules of rhamnose and 10-acetyl group. The glucose 
probably forms a-glucosyl secondary side chains linked 
to carbon 4 of N-acetylglucosamine of the primary 
side chain, as in the la specific structure. Such a suppo- 
sition is possible because the sequence a-glucosyl-l-~4- 
N-acetylglucosamine s involved in antigen type I speci- 
ficity, as proved by Simmons [3]. The repeating unit 
of the O-specific side chain of mutant Z(III) comprises 
N-acetylglucosamine, rhamnose and O-acetyl group in 
the molar proportions 1 : 2 : 1 respectively. As found 
in our study, LPS Z(III) is deficient in a-glucosyl 
secondary side chains, but this is not the case with the 
core structure of the polymer. Thus the mutation of 
serotype lb(I) -+ Z(III) can be explained as a result of 
a defect in the specific UDP glucose transferase that 
is required to transfer the terminal a-glucosyl units 
to N-acetylglucosamine residues in antigen type I. A 
mutation of this kind is consistent with the biosyn- 
thetic pathway predicted by Simmons [3] for Shigella 
flexneri O-antigens. 
On'the other hand Z(III) antigen, in spite of  its dis- 
tinct type III specificity, does not Contain the termi- 
nal O-acetyl-a-glucosyl residues which are found in 
serotype 3a antigen and are suggested to be involved 
in the antigenic factor type III [3]. In the light of  
our findings it seems that not only the O-acetyl-a- 
glucosyl-l-*2-rhamnose configuration is characteristic 
for type III specificity, but also the rhamnose itself 
substituted with an O-acetyl group is sufficient o give 
rise to antigenic factor type III. To get the complete 
analogy between O-specific side chain structures of 
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mutant Z(III) and serotype 3a it should be assumed 
that the same rhamnose of the primary side chain is 
substituted in both cases. The O-specific side chain 
of serotype 3a is, according to Simmons [3], the 
following: 
a-AcGlc 
i 
-GlcNAc- I~3-Rha-I ~4-Rha- 1~ 
a-AcGlc 
~4-GlcNAc- 1~3-Rha-1 ~4-Rha-  
Thus the structure of the O-specific side chain of 
mutant Z(III) seems to be: 
Ac Ac 
-GlcNAc Rha Rha--~GlcNAc Rha Rha-  
As found in this study, the O-specific side chains 
of 1 b(I) antigen were also O-acetylated. The rhanmose 
of O-antigen lb(I) substituted with O=acetyl group is 
supposed to be the same as in O-antigen Z(III). The 
structure for lb(I) O-specific side chain should be the 
following: 
a-Glc a-Glc 
~L'4 Ac Ac 
-GlcNAc~Rha~Rha-~GlcNAc-~Rha~Rha- 
In spite of the O-acetyl-rhamnosyl configuration 
presumably present in LPS lb(I), this antigen reveals 
no type III, but only type I specificity. This fact can 
be explained by the masking effect of the strong 
immunodominant-like a-glucosyl residue located on 
the adjacent 4-O-substituted N-acetylglucosamine. 
The serological evidence obtained in homologous 
complement fixation inhibition studies [13] con- 
firmed the above supposition. With the systems: 
LPS 3a-type III antiserum and LPS Z(III)-type III 
antiserum, the PI fraction of mutant Z(III) was 
found to be a very effective inhibitor (80% and 100% 
inhibition respectively by 2/ag). With the same sys- 
terns, P1 fraction of serotype lb(I) also inhibited, 
although to a smaller extent (about 30% inhibition 
by 5 #g). The cross reaction of P1 fraction of sero- 
type 1 b(I) with type III system implies the presence 
of antigenic factor type III in serotype 1b(I). On the 
other hand no cross reaction between the P1 fraction 
of mutant Z(III) and type I system was found. 
The O-acetyl radicals in LPS 1 b(I) and LPS Z(III) 
are rather stable. The molar ratio of O-acetyl to rham- 
nose amounts to 1:2 in the lipopolysaccharides as 
well as in the O-specific side chains (P1 fractions) 
obtained after CH3COOH hydrolysis. 
Further experiments should be done to define 
exactly the structure of the primary side chain of 
serotype lb(I) and its smooth mutant Z(III). 
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